Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156129 · ClinicalTrials.gov registry record · Phase 1
Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery
A Phase 1 study, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 1
- Development phase
- 111
- Enrollment target
NCT01156129: Completed Phase 1 study, sponsored by University of Nebraska.
NCT01156129 is a Phase 1 study that has completed, run by University of Nebraska. The registered enrollment target is 111 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01156129, a Phase 1 study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 111 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to assess ways to address post-operative ileus (POI) in adult patients on the liver transplant service undergoing either liver transplant or resection surgery. Patient who speak and understand English will be randomized into one of three groups including a.)control group receiving standard therapy for post-operative ileus, b.)group receiving standard therapy and acupressure bracelets, and c.)group receiving standard therapy and sugar free gum four times daily.
Primary Outcome
First bowel movement
Interventions
- DRUG stool softener
- DEVICE Arm B: Acupressure bracelet
- DIETARY_SUPPLEMENT sugar free gum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2010-09-01 |
| Est. Completion | 2012-12-01 |
| Phase | Phase 1 |
What the finished NCT01156129 record still lists
NCT01156129 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% higher).
The record links to 0 conditions, and to 3 interventions - of which stool softener is the first listed.
NCT01156129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01156129 about?
NCT01156129 is a clinical study titled "Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery". This is a randomized controlled trial to assess ways to address post-operative ileus (POI) in adult patients on the liver transplant service undergoing either liver transplant or resection surgery. Patient who speak and understand English will be randomized into one of three groups including a.)cont...
What is the current status of trial NCT01156129?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 111 participants. The study started on 2010-09-01. Estimated completion is 2012-12-01.
What interventions are being tested in trial NCT01156129?
The interventions under investigation include: stool softener (DRUG), Arm B: Acupressure bracelet (DEVICE), sugar free gum (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01156129?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01156129's enrollment target sits among peer trials
111 512th of 2000 higher than 1,487 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI